Osteora
Osteora
High-performance interlocking intramendullary nail systems engineered for immediate clinical application in top Turkish hospitals.
Istanbul stands at the crossroads of Europe and Asia, serving as the commercial and clinical epicenter of Turkey’s rapidly expanding healthcare sector. With the Turkish government’s aggressive investments in mega City Hospitals (Şehir Hastaneleri) and the massive rise of medical tourism from the Middle East, the Balkans, and North Africa, the regional demand for high-performance orthopedic trauma implants—particularly intramedullary nails—has reached unprecedented levels.
Local distributors and procurement officers in Istanbul hospitals require a highly resilient supply chain that balances rigid quality compliance with cost efficiency. Because Turkish public and private hospitals operate under strict budget constraints regulated by the Social Security Institution (SGK) alongside the electronic tracking requirements of the National Drug and Medical Device Databank (ÜTS), partnering directly with a technologically mature manufacturer is essential to secure both regulatory conformity and robust commercial viability.
| Market Metric | Requirement Details |
|---|---|
| Regulatory Clearance | CE MDR (EU 2017/745), ISO 13485 & ÜTS Registration |
| Preferred Materials | Ti-6Al-4V ELI (Grade 5) & Biocompatible PEEK options |
| Key Clinical Sectors | Trauma Centers, Pediatric Orthopedics, Geriatric Fracture Units |
| Supply Chain Need | High-volume elasticity, customized OEM capabilities, and rigid raw material traceability |
A world-class orthopedic manufacturer pioneering trauma, spinal, and joint reconstruction systems.
Osteora Medical Devices Co., Ltd. is a professional orthopedic implant and surgical solution manufacturer specializing in trauma, spine, and joint reconstruction systems under the brand Osteora. Founded in 2016, the company has developed a strong reputation in the global orthopedic industry through continuous innovation and strict quality control standards. The facility covers an area of approximately 18,500㎡, supporting integrated production, assembly, and testing operations.
With 8 years of export experience and 12 years of industry expertise, Osteora has established stable cooperation with international distributors and hospitals across multiple regions. Annual export revenue ranges from USD 6 million to 14 million, reflecting steady global market growth.
The company implements comprehensive quality assurance systems, including ISO 13485 compliance, in-process inspection, and final random sampling testing. Product inspection methods include dimensional measurement, mechanical fatigue testing, and biocompatibility validation. The quality control team consists of 42 specialized inspectors ensuring strict adherence to international medical device standards.
Osteora has a strong trade background in global medical device export and maintains long-term partnerships with distributors in Europe, Southeast Asia, the Middle East, and South America, which are also its primary markets. The company’s supply chain includes approximately 1,200 certified upstream and downstream partners, supporting stable production capacity and reliable delivery performance. Its main customer base consists of hospitals, orthopedic clinics, surgical centers, and medical distributors.
With strong R&D capabilities, Osteora operates an in-house engineering team of 85 R&D engineers, focusing on innovation in trauma fixation systems, spinal implants, and joint reconstruction technologies. The company offers extensive customization options, including OEM/ODM services, size variations, material customization, and private labeling. In the past year, Osteora launched approximately 120 new products, reflecting its continuous investment in innovation and product development to meet evolving clinical needs.
How Osteora's engineering team delivers superior fatigue resistance and anatomical fit for complex fractures.
We source ultra-pure Titanium Alloy (Ti-6Al-4V ELI) and Cobalt-Chromium-Molybdenum alloys. This guarantees an optimized modulus of elasticity that closely mimics human cortical bone, reducing the risk of stress shielding and promoting bone remodeling.
Our Type II anodization surface treatment creates an bio-inert, corrosion-resistant oxide layer. This minimalizes ion release, enhances biocompatibility, and prevents implant-tissue adhesion, making future extraction smoother if required.
Engineered with dual-core reconstruction options, our PFNA and Tibia systems support both dynamic and static locking. This allows surgeons in Istanbul to select the exact compression style needed based on patient bone quality and fracture morphology.
Every batch undergoes rigid testing, including axial compression, torsion, and multi-million cycle dynamic fatigue testing in our in-house laboratories, complying fully with ASTM F382/F543 standards.
An inside look at our 18,500㎡ facility showcasing high-precision machinery, strict testing steps, and full traceability.
Supporting B2B tenders, private labeling, and seamless regulatory integration.
Operating in the Turkish healthcare sector requires aligning with regional specifications. Osteora offers comprehensive localized assistance for our distributors in Istanbul and the broader EMEA region:
Explore our complete range of CE-certified implants designed for femur, tibia, humerus, and pediatric applications.
Technical, commercial, and regulatory guidance for purchasing managers in Turkey and globally.
Whether you represent a major Istanbul medical device distributor or manage orthopedic trauma procurement, our specialists are ready to provide technical parameter lists, pricing tiers, and compliance dossiers.
Send Inquiry Now